Overview

Vitamin D and Calcium Supplementation in Breast Cancer

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
0
Participant gender:
Female
Summary
This study aims at assessing the vitamin Dstatus in breast cancer patients who receive letrozole for more than two months and to evaluate effects of vitamin D3 and calcium supplementation on arthalgia caused by letrozole on these patients.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tanta University
Treatments:
Vitamin D
Criteria
Inclusion Criteria:

- Newly diagnosed breast cancer patients.

- Postmenopausal hormone receptor positive.

- Patients receiving letrozole for more than two months

- Gender: Female.

- Age: ≥ 50 years old.

Exclusion Criteria:

- Patients with bone metastasis.

- History of renal stones.

- Serum calcium >11mg/L.

- Patients with renal insufficiency.

- Patients taking steroid hormone replacement therapy.

- Second Malignancy.